Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 2,193 | 2,818 | 2,316 | 2,233 | 2,769 |
| Gross Profit | 2,193 | 2,818 | 2,316 | 2,233 | 2,769 |
| Operating Expenses | 16,119 | 13,729 | 12,278 | 12,064 | 10,384 |
| Operating Income | -13,926 | -10,911 | -9,962 | -9,831 | -7,615 |
| Other Income | -46,517 | -41,447 | -37,063 | -42,563 | -42,856 |
| Pre-tax Income | -60,443 | -52,358 | -47,025 | -52,394 | -50,471 |
| Net Income Continuous | -60,443 | -52,358 | -47,025 | -52,394 | -50,471 |
| Net Income | $-60,443 | $-52,358 | $-47,025 | $-52,394 | $-50,471 |
| EBITDA(a) | $-13,926 | $-10,911 | $-9,962 | $-9,831 | $-7,615 |